Prevalence and biomarkers of pre-cachexia and cachexia in advanced cancer patients scheduled for treatment with chemotherapy

Completed

• Conditions: cancer; Neoplasms; 10003018; 10027655

• Registration Number: NL-OMON35709
• Lead Sponsor: Vrije Universiteit Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

- Adults (> 18 years);
- Stage III/IV non small cell lung cancer
- Treatment plan: palliative chemotherapy or chemoradiation

Exclusion Criteria

-Ascites (for which treatment is necessary) or serious pitting edema;
-Chemotherapy treatment in the past month;
-Not able to speak the Dutch language;
-Pregnancy.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Prevalence of pre-cachexia and cachexia. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>-The prevalence of pre-cachexia related to tumour type<br /><br>-Potential biomarkers of pre-cachexia will be investigated</p><br>